Early applications are encouraged. Applications submitted by 31 October will be given equal consideration. Applications submitted after this date are not guaranteed to be considered for the January
This programme is subject to revalidation in 2026. Therefore, course content is subject to change for January 2027 entry. Early applications are encouraged. Applications submitted by 31 October will
This project aspires to make immunotherapy safer and more effective by discovering how SGLT2 inhibitors can simultaneously guard the heart and strengthen antitumour immunity. In revealing these
Full Time
4.3